M. L. Blue, J. F. Daley, H. Levine, and S. F. Schlossman, Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry, J. Immunol, vol.134, pp.2281-2286, 1985.

P. Ghia, G. Prato, S. Stella, C. Scielzo, M. Geuna et al., double positive T lymphocytes in the peripheral blood of the elderly, British Journal of Haematology, vol.4, issue.5, pp.780-790, 2007.
DOI : 10.1093/intimm/10.9.1281

Y. Parel and C. Chizzolini, CD4+ CD8+ double positive (DP) T cells in health and disease, Autoimmunity Reviews, vol.3, issue.3, pp.215-220, 2004.
DOI : 10.1016/j.autrev.2003.09.001

A. Bonomo, P. J. Kehn, and E. M. Shevach, Premature escape of doublepositive thymocytes to the periphery of young mice. Possible role in autoimmunity, J. Immunol, vol.152, pp.1509-1514, 1994.

G. Varas and A. , Rat peripheral CD4+CD8+ T lymphocytes are partially immunocompetent thymus-derived cells that undergo post-thymic maturation to become functionally mature CD4+ T lymphocytes, J. Immunol, vol.168, pp.5005-5013, 2002.

X. Paliard, R. W. Malefijt, J. E. De-vries, and H. Spits, Interleukin-4 mediates CDS induction on human CD4+ T-cell clones, Nature, vol.335, issue.6191, pp.642-644, 1988.
DOI : 10.1038/335642a0

M. Gallo and R. C. , Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis, Proc. Natl. Acad. Sci, pp.3111-3116, 1998.

Y. B. Sullivan, A. L. Landay, J. A. Zack, S. G. Kitchen, and L. Harthi, Upregulation of CD4 on CD8+ T cells: CD4dimCD8bright T cells constitute an activated phenotype of CD8+ T cells, Immunology, vol.11, issue.3, pp.270-280, 2001.
DOI : 10.1097/00002030-200005050-00001

N. H. Overgaard, J. Jung, R. J. Steptoe, and J. W. Wells, CD4+/CD8+ double-positive T cells: more than just a developmental stage?, Journal of Leukocyte Biology, vol.97, issue.1
DOI : 10.1189/jlb.1RU0814-382

Y. Parel, M. Aurrand-lions, A. Scheja, J. M. Dayer, E. Roosnek et al., Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum, pp.3459-3467, 2007.

D. 11-quandt, K. Rothe, R. Scholz, C. W. Baerwald, and U. Wagner, Peripheral CD4CD8 Double Positive T Cells with a Distinct Helper Cytokine Profile Are Increased in Rheumatoid Arthritis, PLoS ONE, vol.25, issue.5, p.93293, 2014.
DOI : 10.1371/journal.pone.0093293.g006

A. Waschbisch, L. Sammet, S. Schroder, D. H. Lee, A. Barrantes-freer et al., double-positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions, Clinical & Experimental Immunology, vol.87, issue.2
DOI : 10.1111/cei.12345

J. Hirao and K. Sugita, Circulating CD4+CD8+ T lymphocytes in patients with Kawasaki disease, Clinical and Experimental Immunology, vol.80, issue.2, pp.397-401, 1998.
DOI : 10.1038/335642a0

M. Martinez-gallo, C. Puy, R. Ruiz-hernandez, J. M. Rodriguez-arias, M. Bofill et al., Severe and recurrent episodes of bronchiolitis obliterans organising pneumonia associated with indolent CD4+ CD8+ T-cell leukaemia, European Respiratory Journal, vol.31, issue.6, pp.1368-1372, 2008.
DOI : 10.1183/09031936.00061907

K. Bang, M. Lund, K. Wu, S. C. Mogensen, and K. Thestrup-pedersen, CD4+ CD8+ (thymocyte-like) T lymphocytes present in blood and skin from patients with atopic dermatitis suggest immune dysregulation, British Journal of Dermatology, vol.77, issue.6
DOI : 10.1006/cimm.1995.1140

Y. Wu, J. Farrell, M. Pirmohamed, B. K. Park, and D. J. Naisbitt, Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity, Journal of Allergy and Clinical Immunology, vol.119, issue.4, pp.973-981, 2007.
DOI : 10.1016/j.jaci.2006.12.617

N. A. Giraldo, N. I. Bolanos, A. Cuellar, F. Guzman, A. M. Uribe et al., Increased CD4+/CD8+ Double-Positive T Cells in Chronic Chagasic Patients, PLoS Neglected Tropical Diseases, vol.103, issue.4, p.1294, 2011.
DOI : 10.1371/journal.pntd.0001294.s002

M. Nascimbeni, S. Pol, and B. Saunier, Distinct CD4+ CD8+ doublepositive T cells in the blood and liver of patients during chronic hepatitis B and C. PLoS One, p.20145, 2011.

L. Weiss, A. Roux, S. Garcia, C. Demouchy, N. Haeffner-cavaillon et al., T Lymphocytes that Express Cytotoxicity???Associated Molecules and Are Committed to Produce Interferon????? and Tumor Necrosis Factor?????, The Journal of Infectious Diseases, vol.178, issue.4, pp.1158-1162, 1998.
DOI : 10.1086/515674

M. A. Frahm, R. A. Picking, J. D. Kuruc, K. S. Mcgee, C. L. Gay et al., Response to Comment on "CD4+CD8+ T Cells Represent a Significant Portion of the Anti-HIV T Cell Response to Acute HIV Infection", The Journal of Immunology, vol.188, issue.12, pp.4289-4296, 2012.
DOI : 10.4049/jimmunol.1290029

M. Nascimbeni, E. C. Shin, L. Chiriboga, D. E. Kleiner, and B. Rehermann, Peripheral CD4+CD8+ T cells are differentiated effector memory cells with antiviral functions, Blood, vol.104, issue.2, pp.478-486, 2004.
DOI : 10.1182/blood-2003-12-4395

M. A. Suni, S. A. Ghanekar, D. W. Houck, H. T. Maecker, S. B. Wormsley et al., CD4+CD8dim T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens, European Journal of Immunology, vol.180, issue.8, pp.2512-2520, 2001.
DOI : 10.1002/1521-4141(200108)31:8<2512::AID-IMMU2512>3.0.CO;2-M

A. Zloza, J. M. Schenkel, A. R. Tenorio, J. A. Martinson, P. M. Jeziorczak et al., Potent HIV-specific responses are enriched in a unique subset of CD8+ T cells that coexpresses CD4 on its surface, Blood, vol.114, issue.18, pp.3841-3853, 2009.
DOI : 10.1182/blood-2009-02-202481

A. Zloza, Y. B. Sullivan, E. Connick, A. L. Landay, and L. Harthi, CD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIV, Blood, vol.102, issue.6, pp.2156-2164, 2003.
DOI : 10.1182/blood-2002-07-1972

G. 25-sarrabayrouse, M. Corvaisier, L. H. Ouisse, C. Bossard, L. Mevel et al., Tumor-reactive CD4+CD8????+ CD103+ ????T cells: A prevalent tumor-reactive T-cell subset in metastatic colorectal cancers, International Journal of Cancer, vol.4, issue.suppl 1, pp.2923-2932, 2011.
DOI : 10.1002/ijc.25640

M. Bagot, H. Echchakir, F. Mami-chouaib, M. H. Delfau-larue, D. Charue et al., Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma, Blood, vol.91, pp.4331-4341, 1998.

E. 27-tournier, C. Laurent, M. Thomas, N. Meyer, R. Viraben et al., Double-positive CD4/CD8 mycosis fungoides: a rarely reported immunohistochemical profile, Journal of Cutaneous Pathology, vol.34, issue.1, pp.58-62, 2014.
DOI : 10.1111/cup.12248

R. Wu, J. H. Zippin, and C. Magro, Double-positive CD4(+)CD8(+) Sezary syndrome: an unusual phenotype with an aggressive clinical course

A. 29-rahemtullah, K. K. Reichard, F. I. Preffer, N. L. Harris, and R. P. Hasserjian, A Double-Positive CD4+CD8+ T-Cell Population Is Commonly Found in Nodular Lymphocyte Predominant Hodgkin Lymphoma, American Journal of Clinical Pathology, vol.126, issue.5
DOI : 10.1309/Y8KD32QGRYFN1XQX

J. 30-desfrancois, L. Derre, M. Corvaisier, L. Mevel, B. Catros et al., Increased frequency of nonconventional double positive CD4CD8 ???? T cells in human breast pleural effusions, International Journal of Cancer, vol.179, issue.2, pp.374-380, 2009.
DOI : 10.1002/ijc.24366

J. 31-desfrancois, A. Moreau-aubry, V. Vignard, Y. Godet, A. Khammari et al., Double Positive CD4CD8 ???? T Cells: A New Tumor-Reactive Population in Human Melanomas, PLoS ONE, vol.5, issue.1, p.8437, 2010.
DOI : 10.1371/journal.pone.0008437.t002

S. Perdow-hickman and P. Salgame, Rescue of Human T Cells by Interleukin-9 (IL-9) from IL-2 Deprivation-Induced Apoptosis: Correlation with ?? Subunit Expression of the IL-9 Receptor, Journal of Interferon & Cytokine Research, vol.20, issue.6, pp.603-608, 2000.
DOI : 10.1089/10799900050044804

F. A. Houssiau, J. C. Renauld, M. Stevens, F. Lehmann, B. Lethe et al., Human T cell lines and clones respond to IL-9, J. Immunol, vol.150, pp.2634-2640, 1993.

L. Cosmi, F. Liotta, R. Angeli, B. Mazzinghi, V. Santarlasci et al., Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines, Blood, vol.103, issue.8, pp.3117-3121, 2004.
DOI : 10.1182/blood-2003-09-3302

L. Hultner, C. Druez, J. Moeller, C. Uyttenhove, E. Schmitt et al., Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9), European Journal of Immunology, vol.42, issue.6, pp.1413-1416, 1990.
DOI : 10.1002/eji.1830200632

C. Uyttenhove, R. J. Simpson, and J. Van-snick, Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity., Proc. Natl. Acad. Sci, pp.6934-6938, 1988.
DOI : 10.1073/pnas.85.18.6934

Y. C. Yang, S. Ricciardi, A. Ciarletta, J. Calvetti, K. Kelleher et al., Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40, Blood, vol.74, pp.1880-1884, 1989.

R. J. Noelle and E. C. Nowak, Cellular sources and immune functions of interleukin-9, Nature Reviews Immunology, vol.9, issue.10, pp.683-687, 2010.
DOI : 10.1038/nri2848

R. Goswami and M. H. Kaplan, A Brief History of IL-9, The Journal of Immunology, vol.186, issue.6, pp.3283-3288, 2011.
DOI : 10.4049/jimmunol.1003049

F. 40-vegran, L. Apetoh, and F. Ghiringhelli, Th9 Cells: A Novel CD4 T-cell Subset in the Immune War against Cancer, Cancer Research, vol.75, issue.3, pp.475-479, 2015.
DOI : 10.1158/0008-5472.CAN-14-2748

C. Wilhelm, J. E. Turner, J. Van-snick, and B. Stockinger, The many lives of IL-9: a question of survival?, Nature Immunology, vol.274, issue.7, pp.637-641, 2012.
DOI : 10.1038/ni.2303

H. 42-nakatsukasa, D. Zhang, T. Maruyama, H. Chen, K. Cui et al., The DNA-binding inhibitor Id3 regulates IL-9 production in CD4+ T cells, Nature Immunology, vol.513, issue.10, pp.1077-1084, 2015.
DOI : 10.1038/ni.1997

R. 43-purwar, C. Schlapbach, S. Xiao, H. S. Kang, W. Elyaman et al., Robust tumor immunity to melanoma mediated by interleukin-9???producing T cells, Nature Medicine, vol.178, issue.8, pp.1248-1253, 2012.
DOI : 10.1097/SHK.0b013e31821af669

J. Van-snick, A. Goethals, J. C. Renauld, E. Van-roost, C. Uyttenhove et al., Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40), Journal of Experimental Medicine, vol.169, issue.1, pp.363-368, 1989.
DOI : 10.1084/jem.169.1.363

A. S. Gounni, B. Gregory, E. Nutku, F. Aris, K. Latifa et al., Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils, Blood, vol.96, pp.2163-2171, 2000.

R. H. Fontaine, O. Cases, V. Lelievre, B. Mesples, J. C. Renauld et al., IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. Cell Death Differ, pp.1542-1552, 2008.

L. 47-knoops and J. C. Renauld, IL-9 and its Receptor: From Signal Transduction to Tumorigenesis, Growth Factors, vol.22, issue.4, pp.207-215, 2004.
DOI : 10.1080/08977190410001720879

G. K. Singhera, R. Macredmond, and D. R. Dorscheid, INTERLEUKIN-9 AND -13 INHIBIT SPONTANEOUS AND CORTICOSTEROID INDUCED APOPTOSIS OF NORMAL AIRWAY EPITHELIAL CELLS, Experimental Lung Research, vol.89, issue.9, pp.579-598, 2008.
DOI : 10.3324/haematol.10543

B. Arendse, J. Van-snick, and F. Brombacher, IL-9 Is a Susceptibility Factor in Leishmania major Infection by Promoting Detrimental Th2/Type 2 Responses, The Journal of Immunology, vol.174, issue.4, pp.2205-2211, 2005.
DOI : 10.4049/jimmunol.174.4.2205

P. G. Fallon, P. Smith, E. J. Richardson, F. J. Jones, H. C. Faulkner et al., Expression of Interleukin-9 Leads to Th2 Cytokine-Dominated Responses and Fatal Enteropathy in Mice with Chronic Schistosoma mansoni Infections, Infection and Immunity, vol.68, issue.10, pp.6005-6011, 2000.
DOI : 10.1128/IAI.68.10.6005-6011.2000

L. F. Poulin, C. Habran, P. Stordeur, M. Goldman, A. Mckenzie et al., Interleukin-9 stimulates the production of interleukin-5 in CD4+ T cells. Eur. Cytokine Netw, pp.233-239, 2005.

U. A. 52-temann, P. Ray, and R. A. Flavell, Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology, Journal of Clinical Investigation, vol.109, issue.1
DOI : 10.1172/JCI0213696

S. 53-dragon, M. K. Takhar, L. Shan, K. T. Hayglass, F. E. Simons et al., TH2 cytokines modulate the IL-9R expression on human neutrophils, H)2 cytokines modulate the IL-9R expression on human neutrophils, pp.167-172, 2009.
DOI : 10.1016/j.bbrc.2009.04.104

J. 54-louahed, A. Kermouni, J. Van-snick, and J. C. Renauld, IL-9 induces expression of granzymes and high-affinity IgE receptor in murine T helper clones, J. Immunol, vol.154, pp.5061-5070, 1995.

M. Terabe, J. M. Park, and J. A. Berzofsky, Role of IL-13 in regulation of anti-tumor immunity and tumor growth, Cancer Immunology, Immunotherapy, vol.53, issue.2, pp.79-85, 2004.
DOI : 10.1007/s00262-003-0445-0

I. K. Kim, B. S. Kim, C. H. Koh, J. W. Seok, J. S. Park et al., Glucocorticoid-induced tumor necrosis factor receptor???related protein co-stimulation facilitates tumor regression by inducing IL-9???producing helper T cells, Nature Medicine, vol.21, issue.9, pp.1010-1017, 2015.
DOI : 10.1111/j.1365-2567.2006.02453.x

E. Schmitt and T. Bopp, Amazing IL-9: revealing a new function for an ???old??? cytokine, Journal of Clinical Investigation, vol.122, issue.11, pp.3857-3859, 2012.
DOI : 10.1172/JCI65929

Y. Lu, S. Hong, H. Li, J. Park, B. Hong et al., Th9 cells promote antitumor immune responses in vivo, Journal of Clinical Investigation, vol.122, issue.11, pp.4160-4171, 2012.
DOI : 10.1172/JCI65459DS1

A. S. Gounni, Q. Hamid, S. M. Rahman, J. Hoeck, J. Yang et al., IL-9-Mediated Induction of Eotaxin1/CCL11 in Human Airway Smooth Muscle Cells, The Journal of Immunology, vol.173, issue.4, pp.2771-2779, 2004.
DOI : 10.4049/jimmunol.173.4.2771

Y. Lu, B. Hong, H. Li, Y. Zheng, M. Zhang et al., Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers, Proceedings of the National Academy of Sciences, vol.111, issue.6
DOI : 10.1073/pnas.1317431111

M. Dougan and G. Dranoff, Immune Therapy for Cancer, Annual Review of Immunology, vol.27, issue.1, pp.83-117, 2009.
DOI : 10.1146/annurev.immunol.021908.132544

M. H. Hashmi and P. J. Van-veldhuizen, Interleukin-21: updated review of Phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refractory indolent non-Hodgkin's lymphoma, Expert Opinion on Biological Therapy, vol.26, issue.9, pp.807-817, 2010.
DOI : 10.1016/S0140-6736(08)61039-9

N. Gervois, N. Labarriere, L. Guiner, S. Pandolfino, M. C. Fonteneau et al., High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells, Clin. Cancer Res, vol.6, pp.1459-1467, 2000.